Thrombosis and bleeding outcomes with warfarin conversion to rivaroxaban during the COVID19 pandemic

Simple item page
dc.article.end-page45en
dc.article.start-page39en
dc.citation.doi10.7196/SAMJ.2025.V115I9.3503en
dc.contributor.authorChing-Yu Wangen
dc.contributor.authorElise Schapkaitzen
dc.contributor.authorSusan Louwen
dc.contributor.authorBarry Jacobsonen
dc.date.accessioned2026-03-04T09:03:02Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0256-9574en
dc.identifier.urihttps://hdl.handle.net/10539/48431
dc.journal.titleThrombosis and bleeding outcomes with warfarin conversion to rivaroxaban during the COVID19 pandemicen
dc.journal.volume115en
dc.titleThrombosis and bleeding outcomes with warfarin conversion to rivaroxaban during the COVID19 pandemicen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
191.44 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)